We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Intervertebral Discs Bioengineered in the Laboratory

By LabMedica International staff writers
Posted on 29 Jan 2009
A new collaboration between U.S. More...
physician-scientists has led to the creation of bioengineered intervertebral discs (IVDs) in the laboratory, for transplantation into the spines of rats.

Each year, 40-60% of adults suffer from chronic back pain in the United States alone. For patients diagnosed with severe degenerative disc disease, neurosurgeons must perform surgery called discectomy--removing the IVD--followed by a fusion of the vertebrate bones to stabilize the spine. Even after all that effort, the patient's back, in all probability, will not feel the same as before their injury.

To create new spine discs, Drs. Roger Härtl and Lawrence Bonassar from Weill Cornell Medical College (New York, NY, USA) and basic science researchers at Cornell University (Ithaca, NY, USA) are using cells from IVD tissue of human patients who have had their spinal discs removed. Dr. Härtl is a well-known neurologic surgeon at New York-Presbyterian Hospital/Weill Cornell Medical Center (New York, NY, USA), and assistant professor of neurological surgery at Weill Cornell Medical College, and Dr. Bonassar is an associate professor in the departments of biomedical engineering and mechanical and aerospace engineering at Cornell University.

In the process, Dr. Härtl harvests tissue from the removed discs and sends it to Dr. Bonassar. Cells are then isolated from this tissue and grown in an incubator that simulates the environment in the body. Once developed, they are placed on a bioengineered scaffold, enabling the assembly of the cells and scaffold into an IVD-shaped implant. The researchers then surgically implant the discs inside a rat's spine in order to see how the tissue reacts to the mechanical and biologic demands. So far, results are promising.

The researchers hope to soon evaluate the bioengineered discs in human subjects in a clinical trial, so that someday individuals can receive spare parts for their aging or injured backs.

Related Links:
Weill Cornell Medical College


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Pipette Calibration System
Artel PCS®
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.